Will anxiety that occurs after discontinuing metoprolol begin to subside around day 8?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Metoprolol Withdrawal Anxiety Timeline

Yes, anxiety symptoms from metoprolol withdrawal typically peak between days 2-8 and should begin subsiding around day 8, with most symptoms resolving by 2-3 weeks after discontinuation.

Evidence-Based Timeline

The FDA label explicitly warns against abrupt discontinuation of metoprolol, particularly in patients with coronary artery disease, recommending gradual dose reduction over 1-2 weeks 1. However, the specific timeline for withdrawal symptoms has been well-characterized in research studies.

Peak Withdrawal Period (Days 2-8)

Research demonstrates that rebound phenomena occur maximally between 2-8 days after abrupt metoprolol withdrawal 2. In a controlled study of 8 patients on metoprolol 300 mg/day, investigators documented:

  • 52% average rebound increase in cardiac sensitivity to stress
  • 15% rebound rise in resting heart rate
  • Peak symptoms occurring between days 2-8
  • Withdrawal-like symptoms (including anxiety, palpitations, tremor) noted in 3 of 8 patients 2

A larger study of 115 post-infarction patients showed that mental symptoms and increased cardiac symptoms occurred significantly more frequently during the first month after withdrawal, with the most intense period being the first 2-3 weeks 3.

Resolution Phase (After Day 8)

The same research indicates that beta-adrenergic sensitivity returns to baseline levels by days 14-21 2, 4. Another comparative study found that after metoprolol, cardiac sensitivity remained elevated 2-3 fold below baseline from days 2-8, then normalized 4.

Clinical Implications

Why Day 8 Matters

Day 8 represents the transition point where:

  • Peak rebound beta-adrenergic hypersensitivity begins to decline
  • Anxiety and palpitation symptoms start improving
  • Heart rate begins returning toward baseline

Important Caveats

Gradual withdrawal reduces but does not eliminate symptoms: When metoprolol was tapered to 50 mg/day for 10 days before complete discontinuation, withdrawal phenomena decreased but were not completely prevented 2. This suggests that even with your current timeline at day 8, some residual symptoms may persist for another 1-2 weeks.

Individual variation exists: The severity and duration depend on:

  • Original dose (higher doses = more pronounced withdrawal)
  • Duration of therapy (longer treatment = more receptor upregulation)
  • Presence of underlying cardiac disease
  • Individual metabolic differences

What to Expect Going Forward

From day 8 onward, you should experience:

  • Gradual improvement in anxiety symptoms over the next 1-2 weeks
  • Heart rate stabilization by days 14-21
  • Complete resolution of withdrawal phenomena by 3 weeks post-discontinuation 2, 3

Safety Considerations

The FDA warns that abrupt discontinuation can cause severe exacerbation of angina, myocardial infarction, and ventricular arrhythmias in patients with coronary artery disease 1. If you experience:

  • Severe chest pain
  • Marked worsening of anxiety beyond what you've already experienced
  • Significant palpitations or irregular heartbeat

Contact your physician immediately, as metoprolol may need to be temporarily reinstated 1.

The anxiety you're experiencing at day 8 is consistent with the expected withdrawal timeline and should begin improving over the next week.

Related Questions

How will my heart rate be affected after missing metoprolol for approximately 23 hours?
I rapidly reduced my metoprolol (beta‑blocker) dose from 23.5 mg to 12.5 mg after being off it for six months, and now have more frequent premature ventricular contractions and supraventricular tachycardia episodes; could this be a rebound effect from beta‑blocker withdrawal, and will restarting metoprolol return my arrhythmia to baseline?
How long do withdrawal symptoms last after abruptly stopping metoprolol?
In a 31‑year‑old woman on propranolol who experiences brief episodes of tachycardia 170–180 bpm with shortness of breath and oxygen saturation 89–90 % at rest (including while lying down), similar episodes occurred during a prior pregnancy and were previously attributed to anxiety; what is the likely etiology and what urgent cardiac evaluation and management steps are recommended?
After stopping metoprolol six months ago, I am experiencing frequent supraventricular tachycardia episodes and wave-like adrenaline rushes—could these be lasting effects of metoprolol, and how should they be managed?
Is cannabis use safe during pregnancy, and what management strategies should be recommended?
What are the recommended dosing regimens, monitoring requirements, contraindications, and alternative therapies for cladribine in relapsing‑remitting multiple sclerosis and hairy cell leukemia?
What is the ICD‑10 code for self‑Foley catheterization?
Can propranolol cause itching or tingling sensations that start on the scalp and spread, together with shortness of breath and dizziness on standing, in a gardener?
How should acute metacarpophalangeal (knuckle) pain be evaluated and managed?
Can warfarin (a vitamin K antagonist anticoagulant) cause sensorineural hearing loss?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.